Systematic review shows a 133% rise in cutaneous leishmaniasis incidence in Pakistan, highlighting urban risks and control efficacy.
Cutaneous Leishmaniasis (CL) is a major public health concern in Pakistan, with an increasing incidence and new complexity in transmission dynamics, diagnosis, and treatment. This systematic review synthesizes findings from 100 papers (2015-2024) to examine the epidemiology, risk factors, molecular trends, and control measures for CL across different ecological zones of Pakistan. The study found a 133% increase in reported cases (from 12,000 in 2015 to 28,100 in 2024; χ² = 47.3, *p* < 0.001), with hyper endemic clustering in Khyber Pakhtunkhwa (42.3%), Baluchistan (31.1%), and Punjab's Thal Desert (19.2%) (Moran's I = 0.51, *p* = 0.008). Urban centers have a 2.24-fold greater prevalence than rural locations (15.2 vs. 6.8 per 10,000; OR = 2.9, 95% CI: 2.1-4.0), owing to overcrowding and inadequate sanitation. Molecular analysis of 1,200 isolates reveals that Leishmania tropica (67.8%) is the leading urban pathogen, while L. major (29.3%) predominates in dry locations. Two unique L. tropica genotypes (T3/T4) exhibit multidrug resistance, with treatment failure rates of 40.2% (RR = 1.8, *p* = 0.01). Sand-fly vector dynamics show temperature-dependent transmission, with Phlebotomus sergenti (urban, *r* = 0.78) and P. papatasi (rural, *r* = 0.82) abundances substantially associated with warming trends. Poverty (OR = 3.5, PAF = 41.2%), bad housing (OR = 2.8), and refugee status (OR = 2.6) are identified as significant socioeconomic variables. Control treatments have varying efficacy: indoor residual spraying lowers incidence by 40.8% (95% CI: 35.2-46.4%), exceeding insecticide-treated nets (33.7%) but at a higher cost. The emergence of antimonial-resistant strains and climate-induced vector expansion pose a danger to long-term control, demanding integrated solutions that include precision mapping, species-specific medicines, and community engagement. This analysis emphasizes the critical need for a national surveillance system, climate-adaptive solutions, and cross-sectoral coordination to reduce Pakistan's expanding CL burden in the face of ecological and demographic change.
No takes yet. Share an insight, caveat, or question.
Wasia Ullah (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: